Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Still Down 90%, Here's Why Teladoc Health Stock Is a Buy After Earnings


It's been a brutal couple of years for investors in telehealth specialist Teladoc Health (NYSE: TDOC), with shares down almost 90% from the all-time high. But there are some real positives happening with the business. In the video below, Motley Fool contributors Jeff Santoro and Jason Hall dig into the third-quarter results, and offer their analysis of the good and the bad for Teladoc right now, and why they think it's a buy. 

*Stock prices used were the after-market prices of Oct. 28, 2022. The video was published on Oct. 28, 2022.

Continue reading


Source Fool.com

Like: 0
Share

Comments